Neurologix receives additional $7 million financing - MarketLine Financial Deals

Neurologix receives additional $7 million financing

Neurologix receives additional $7 million financing - MarketLine Financial Deals
Neurologix receives additional $7 million financing
Published Dec 06, 2010
4 pages — Published Dec 06, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Neurologix, Inc., a US-based biotechnology company focused on the disorders of the brain and Central Nervous System, has received $7 million additional financing.

  
Source:
Document ID
MA41413_101208
Country
Ticker
NRGX=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Neurologix receives additional $7 million financing" Dec 06, 2010. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Neurologix-receives-additional-7-million-financing-2052-48433>
  
APA:
MarketLine Financial Deals. (2010). Neurologix receives additional $7 million financing Dec 06, 2010. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Neurologix-receives-additional-7-million-financing-2052-48433>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.